DrugPatentWatch Database Preview
INFUMORPH Drug Profile
Email this page to a colleague
See Plans and PricingWhen do Infumorph patents expire, and when can generic versions of Infumorph launch?
Infumorph is a drug marketed by West-ward Pharms Int and is included in one NDA.
The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Infumorph
A generic version of INFUMORPH was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for INFUMORPH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 17 |
| Clinical Trials: | 3 |
| Patent Applications: | 7,964 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for INFUMORPH |
| DailyMed Link: | INFUMORPH at DailyMed |
Recent Clinical Trials for INFUMORPH
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Abdelrady S Ibrahim, MD | Phase 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
| Duke University | Phase 4 |
Pharmacology for INFUMORPH
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Synonyms for INFUMORPH
| (-)-(etorphine) |
| (-)-Morphine |
| (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| (-)Morphine sulfate |
| (1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18),15-tetraene-10,14-diol |
| (1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0;{1,13}.0;{5,17}.0;{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| (1S,5R,13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol |
| (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL |
| (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol |
| (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| (5alpha,6beta)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol |
| (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol |
| (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL |
| (Morphine) |
| (morphine) 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| 1325730-46-8 |
| 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol |
| 2-{4-[2,4-diamino-6-pteridinylmethyl(methyl)amino]phenylcarboxamido}pentanedioic acid(morphine) |
| 3-(4-Hydroxy-phenyl)-1-propyl-piperidine-3-carboxylic acid ethyl ester |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ; HydroChloride |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ;sulphate salt(morphine) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol,sulfate(Morphinesulfate) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol((Morphine)) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine sulfate) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine)(HCl) |
| 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diolMorphine |
| 4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| 4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol (morphine) |
| 4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine) |
| 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol |
| 47106-99-0 |
| 57-27-2 |
| 6-tert-Butyl-3-methyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine |
| 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Morphine) |
| 6211-15-0 (sulfate (2:1) (salt) pentahydrate) |
| 64-31-3 (sulfate (2:1) (salt) anhydrous) |
| 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol |
| 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol(morphine) |
| 76I7G6D29C |
| 8053-16-5 |
| 85201-37-2 |
| 863713-90-0 |
| 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl- |
| 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl- |
| Aguettant |
| AKOS015966554 |
| AN-23579 |
| AN-23737 |
| Astramorph PF |
| Avinza |
| BDBM50000092 |
| BIDD:GT0147 |
| BQJCRHHNABKAKU-KBQPJGBKSA-N |
| C01516 |
| CCRIS 5762 |
| CHEBI:17303 |
| CHEMBL3978843 |
| CHEMBL70 |
| Cube juice |
| D-(-)-Morphine |
| D08233 |
| DB00295 |
| DEA No. 9300 |
| DepoDur |
| Dimorf |
| Dinamorf |
| Dolcontin |
| Dreamer |
| DTXSID9023336 |
| Dulcontin |
| Duramorph |
| Duramorph PF |
| Duromorph |
| EINECS 200-320-2 |
| Epimorph |
| Epitope ID:116646 |
| GTPL1627 |
| Hard stuff |
| Hocus |
| HSDB 2134 |
| Kadian |
| l-Morphine |
| LS-91748 |
| M-Eslon |
| M.O.S |
| Meconium |
| methyl[?]diol |
| MOI |
| Morfina |
| Morfina [Italian] |
| Morfina Dosa (TN) |
| Morphia |
| Morphin |
| Morphin [German] |
| Morphina |
| Morphina [Italian] |
| Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl- |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)- |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)- |
| Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)- |
| morphine |
| Morphine (BAN) |
| Morphine [BAN] |
| Morphine 0.1 mg/ml in Methanol |
| Morphine 1.0 mg/ml in Methanol |
| Morphine Anhydrate |
| Morphine Extra-Forte |
| Morphine Forte |
| Morphine H.P |
| Morphine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| MORPHINE SULFATE |
| MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE |
| Morphine;4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol |
| Morphinism |
| Morphinum |
| Morphitec |
| Morphium |
| Morpho |
| Moscontin |
| MS Contin |
| Ms Emma |
| MS/L |
| MS/S |
| Mscontin, Oramorph |
| MSIR |
| Nepenthe |
| NSC11441 |
| OMS Concentrate |
| Oramorph |
| Oramorph SR |
| Ospalivina |
| Rescudose |
| RMS |
| RMS Uniserts |
| Roxanol |
| Roxanol 100 |
| Roxanol UD |
| SCHEMBL2997 |
| SDZ 202-250 |
| SDZ202-250 |
| Sevredol |
| Statex Drops |
| Statex SR |
| Substitol (TN) |
| UNII-1M5VY6ITRT component BQJCRHHNABKAKU-KBQPJGBKSA-N |
| UNII-76I7G6D29C |
| Unkie |
| ZINC3812983 |
US Patents and Regulatory Information for INFUMORPH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-003 | Jul 19, 1991 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| West-ward Pharms Int | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-004 | Jul 19, 1991 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
